Taking aspirin was first linked to a lower risk of colorectal cancer in 1988, but the research into its anti-tumour potential ...

Aspirin use is associated with an increased risk for acute kidney injury in critical patients with chest trauma, whereas ibuprofen and ketorolac show no significant association, a study suggests.

Paracetamol, aspirin and ibuprofen are among the most widely used. While they are all effective for pain relief, they each ...

Essentially, aspirin can boost the immune system’s ability to fight cancer metastasis by stopping platelets — tiny blood ...

Aspirin, one of the world’s most common over-the-counter painkillers, could help fight cancer, a new study, published in ...

Could aspirin keep cancer from spreading? A new study from the University of Cambridge suggests that the common pain ...

While previous research hinted at a link between aspirin use and improved cancer survival, a study published in Nature last week explains why. However, experts caution that aspirin is not a cure ...

A major new study published in JAMA Oncology reveals that regular aspirin use could significantly lower the risk of developing colorectal cancer — particularly for people who don’t maintain ...

People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open ...

The findings support current guidelines recommending low-dose aspirin (81 mg) as an effective preventive measure for ...

Please provide your email address to receive an email when new articles are posted on . Daily aspirin use after adjuvant therapy did not improve outcomes for patients with colorectal cancer.

Allied Market Research published a report, titled, "Aspirin Drugs Market by Dosage Form (Tablets, Capsules, and Others), ...